Thursday, February 16, 2023

IRS NEWS "A doctor who owns a medical clinic in Newark today admitted defrauding New Jersey state and local health benefits programs and other insurers by submitting fraudulent claims for medically unnecessary prescriptions, Attorney for the United States Vikas Khanna announced."

https://www.irs.gov/compliance/criminal-investigation/doctor-admits-health-care-fraud-conspiracy 

 

Tuesday, February 14, 2023

Pharmacy Decision Affirmed on Appeal Regarding rule relating to compounding preparations that are essential copies of commercial drugs Empower Drugs v. Iowa Board of Pharmacy

 

in the court of appeals of iowa

7 days ago — Compounded drug products serve an important role for patients whose clinical needs cannot be met by an FDA-approved drug product, such as a patient who has ..https://www.iowacourts.gov/courtcases/17360/embed/CourtAppealsOpinion

 

Compounded-Drug-Products-Aetna-Medicaid-Policy-ua.pdf

4 days ago — The intent of this policy/guideline is to provide information to the prescribing practitioner outlining the coverage criteria for compounded drug products under .

Announcement from Walter Reed regarding Compounded Drugs-Adopts Express Scripts Incorporated Commercial Reject List

 "

Notice of Non-coverage for Certain Compounded Drugs

Posted February 13, 2023

A review by the Pharmacy Advisory Board of the Defense Health Agency (DHA) found compounded drugs, which traditionally accounted for a small proportion of pharmaceutical expenditures, grew to over $500 million by 2015. The dramatic increase was largely due to multiple fraudulent schemes related to drug compounding and billing.

To combat fraud and ensure patient safety, DHA adopted the Express Scripts Incorporated (ESI) Commercial Reject List. The ESI’s Commercial Reject List verifies that each ingredient is safe, effective, and covered by TRICARE. With the current implementation of the DHA’s new electronic health record, MHS GENESIS, only compounds recognized by ESI, covered for the indication prescribed, and approved for standardized use, will be compounded by National Capital Region (NCR) Market pharmacies...."https://walterreed.tricare.mil/News-Gallery/Alerts/Compounded-Medications

FDA updates ibuprofen compounding guidance  | AHA News

FDA updates ibuprofen compounding guidance  | AHA News: The Food and Drug Administration yesterday revised its recent guidance for outsourcing facilities compounding certain ibuprofen oral suspension products.

Wednesday, February 8, 2023

 Opinion: Poodle's death after vet visit shows why Texas Vet Board needs revamp - The Dallas Morning News



https://apple.news/AZXoTRBTHSS-y67kzUvxmng

 


FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds